Reading AVTR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AVTR free→Reading AVTR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track AVTR free→QuarterlyIQ Insights · AVTR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On April 29, 2026, Avantor, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information contained in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 17, 2026, Avantor, Inc. (the “Company”) informed Benoit Gourdier, the Company’s Executive Vice President, Bioscience and Medtech Products, that he would be transitioning to a new role supporting the Company’s segment integration activities, after which it is expected that he would depart the Company no later than December 31, 2026.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 26, 2026, Mr. R. Brent Jones notified Avantor, Inc. (the “Company”) of his decision to resign as the Company’s Executive Vice President and Chief Financial Officer (“CFO”) to join a company outside the life sciences industry. While a final departure date has not been set, Mr. Jones’ employment agreement requires him to provide 90 days’ not…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 17, 2025, Avantor, Inc. (the “Company”) filed a Current Report on Form 8-K announcing the election of Simon Dingemans as a director of the Company effective January 2, 2026. The prior report did not include the committees of the Board of Directors that Mr. Dingemans was named to because the Board had not determined on which committees o…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 4, 2025, Avantor, Inc. (the “Company”) filed a Current Report on Form 8-K announcing the election of Sanjeev Mehra as a director of the Company effective December 4, 2025. The prior report did not include the committees of the Board of Directors that Mr. Mehra was named to because the Board had not determined on which committees of the…
above, which also announced a realignment of the Company’s reportable business segments. The Company will hold a conference call to discuss these developments and its financial results for the quarter and year ended December 31, 2025 at 8:00 a.m. ET on February 11, 2026. Effective in the first quarter of 2026, the Company is realigning its business units into two reportable segments: VWR Distribution & Services and Bioscience & Medtech Products. To assist investors in understanding the effect…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 10, 2025, Jonathan Peacock informed Avantor, Inc. (the “Company”) that he will step down as the Company’s chairman, member of the Board of Directors (the “Board”) and member of the Nominating and Governance Committee on December 31, 2025. Mr. Peacock’s decision to step down from the Board was not a result of any disagreement with the Com…
Entry into a Material Definitive Agreement. Senior Secured Credit Facilities Amendment On October 9, 2025, Avantor Funding, Inc. (the “Borrower”), a wholly-owned subsidiary of Avantor, Inc. (the “Company”), certain other subsidiaries of the Company, the lenders party thereto, and Goldman Sachs Bank USA, as administrative agent and collateral agent, entered into Amendment No. 14 to Credit Agreement (the “Amendment”), which amends the Credit Agreement dated as of November 21, 2017, as previousl…
Creation of a Direct Financial Obligation under an Off-Balance Sheet Arrangement of Registrant. The information set forth in
Termination of a Material Agreement. PNC A/R Facility Termination On October 9, 2025 (the “Termination Date”), certain subsidiaries of the Company entered into an Assignment and Termination Agreement (the “Termination Agreement”) with PNC Bank, National Association (the “Bank”), as administrator, purchaser agent, related committed purchaser, LC bank and LC participant, and Wells Fargo Bank, National Association, as purchaser agent, related committed purchaser and LC participant, pursuant to w…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 1, 2025, the Board of Directors (the “Board”) of Avantor, Inc. (the “Company”), upon the recommendation of its Nominating and Governance Committee, elected Gregory Lucier as a director, effective as of October 3, 2025, with an initial term expiring on the date of the Company’s 2026 Annual Meeting of Stockholders. Mr. Lucier, age 61, curr…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.